FERRI, Clodoveo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.686
EU - Europa 25.298
AS - Asia 17.614
SA - Sud America 2.139
AF - Africa 263
Continente sconosciuto - Info sul continente non disponibili 39
OC - Oceania 39
Totale 96.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 50.240
GB - Regno Unito 9.905
IT - Italia 6.597
CN - Cina 5.905
SG - Singapore 5.173
HK - Hong Kong 2.743
SE - Svezia 1.968
BR - Brasile 1.739
DE - Germania 1.486
UA - Ucraina 1.404
TR - Turchia 1.378
FI - Finlandia 952
RU - Federazione Russa 820
FR - Francia 778
VN - Vietnam 641
BG - Bulgaria 496
KR - Corea 466
IN - India 355
ID - Indonesia 239
CA - Canada 199
NL - Olanda 198
IE - Irlanda 197
AR - Argentina 159
JP - Giappone 154
MX - Messico 136
ZA - Sudafrica 123
PL - Polonia 85
BD - Bangladesh 82
ES - Italia 69
IR - Iran 67
BZ - Belize 66
EC - Ecuador 66
BE - Belgio 58
AE - Emirati Arabi Uniti 55
IQ - Iraq 53
MY - Malesia 53
AT - Austria 43
CL - Cile 42
RO - Romania 41
LT - Lituania 39
CO - Colombia 36
EU - Europa 34
PK - Pakistan 34
MA - Marocco 33
AU - Australia 31
SA - Arabia Saudita 30
EG - Egitto 27
PY - Paraguay 27
UZ - Uzbekistan 27
CH - Svizzera 26
VE - Venezuela 26
KE - Kenya 19
PE - Perù 19
CZ - Repubblica Ceca 18
IL - Israele 18
TW - Taiwan 18
PT - Portogallo 17
TN - Tunisia 17
JO - Giordania 16
NP - Nepal 16
AZ - Azerbaigian 14
TH - Thailandia 14
KG - Kirghizistan 12
LV - Lettonia 12
PH - Filippine 12
UY - Uruguay 12
BO - Bolivia 11
HU - Ungheria 11
NO - Norvegia 10
AL - Albania 9
BY - Bielorussia 9
DO - Repubblica Dominicana 9
GR - Grecia 9
OM - Oman 9
TT - Trinidad e Tobago 9
LU - Lussemburgo 8
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
CI - Costa d'Avorio 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
JM - Giamaica 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
PA - Panama 4
RS - Serbia 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CR - Costa Rica 3
GH - Ghana 3
GT - Guatemala 3
MK - Macedonia 3
NI - Nicaragua 3
SI - Slovenia 3
BH - Bahrain 2
BW - Botswana 2
Totale 96.025
Salva come PNG Salva come JPEG
Città #
Southend 7.726
Fairfield 5.008
Santa Clara 3.984
Woodbridge 3.480
Singapore 3.346
Ashburn 3.130
Jacksonville 2.762
Hong Kong 2.735
Houston 2.671
Chandler 2.065
Hefei 1.956
Ann Arbor 1.930
Seattle 1.795
Wilmington 1.787
Chicago 1.746
Dearborn 1.674
Cambridge 1.605
Los Angeles 1.356
London 1.158
Nyköping 1.083
Beijing 936
Izmir 824
Salt Lake City 766
Modena 622
San Diego 524
Princeton 523
Helsinki 503
The Dalles 503
Sofia 490
Milan 481
Eugene 448
New York 444
Rome 420
Seoul 419
Tampa 375
Elk Grove Village 337
Council Bluffs 316
Buffalo 279
Dallas 278
Des Moines 247
Moscow 244
Columbus 243
San Jose 229
Shanghai 218
Ho Chi Minh City 211
Atlanta 202
Jakarta 193
Redwood City 179
Bremen 169
Dublin 168
Sterling 168
São Paulo 159
Hanoi 155
Lancaster 149
Bologna 125
Frankfurt am Main 125
Guangzhou 121
Boardman 110
Florence 110
Norwalk 110
Dulles 103
Miami 103
Detroit 95
Naples 95
Tokyo 95
Falls Church 94
Phoenix 94
Palermo 92
Delhi 84
Turin 81
New Delhi 73
Munich 72
Genoa 70
Istanbul 70
Nanjing 70
Bari 69
Kansas City 68
Verona 67
Belize City 66
Catania 66
Denver 62
Warsaw 62
Toronto 58
Brooklyn 57
Dong Ket 56
Jinan 56
Kunming 53
Montreal 53
Johannesburg 52
Pittsburgh 52
Padova 51
Brussels 50
Redondo Beach 49
Belo Horizonte 48
Mexico City 48
Zhengzhou 46
Hounslow 44
San Francisco 41
Cagliari 40
Wuhan 40
Totale 68.765
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.730
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 872
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 740
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 736
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 507
Semeiotica dell'articolazione temporo-mandibolare 494
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 412
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 408
B-cells and mixed cryoglobulinemia 403
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 397
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 392
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 391
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 377
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 359
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 356
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 351
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 350
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 345
Endocrine manifestations of hepatitis C virus infection. 342
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 342
Thymus alterations and systemic sclerosis 341
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 340
Validation of the classification criteria for cryoglobulinaemic vasculitis 336
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 335
Heart involvement and systemic sclerosis 332
Systemic sclerosis in childhood - Clinical and immunologic features of 153 patients in an international database 330
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides 330
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 329
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 329
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 328
Scleroderma digital ulcers complicated by infection with fecal pathogens. 322
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 322
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 320
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 316
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 314
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. 311
Current treatment of hepatitis C-associated rheumatic diseases. 310
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 310
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 306
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 306
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 305
Aortic pulse wave velocity measurement in systemic sclerosis patients. 304
Cardiac Involvement in Systemic Vasculitis 303
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 302
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 301
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 300
L-Arginine in pregnant scleroderma patients 300
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 297
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 295
The A, B, Cs of viral hepatitis in the biologic era. 294
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 294
Staphylococcus protein A-based extracorporeal immunoadsorption and thalidomide in the treatment of skin manifestation of dermatomyositis: a case report. 294
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 294
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change 293
Non HCV-related mixed cryoglobulinemia 291
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 289
Elevated Troponin Serum Levels in Adult Onset Still's Disease 287
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 286
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 286
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 284
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 284
Platelet gel in the treatment of severe scleroderma skin ulcers. 283
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 283
HCV and cryoglobulinemic vasculitis. 282
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 281
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 280
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 279
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 278
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 278
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 277
Role of the HLA class II: HCV-related disorders 277
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 275
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 275
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 274
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 273
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 273
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry. 273
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. 268
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection. 268
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia 268
GISEA: an Italian biological agents registry in rheumatology 267
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 266
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 265
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 264
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 264
Cytokines and HCV-related disorders 263
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 262
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 261
Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. 261
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 261
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 260
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 260
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 260
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 259
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 258
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 258
Incidence and characteristics of non-hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias 256
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 255
Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach 255
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 254
Totale 35.408
Salva come PNG Salva come JPEG
Categoria #
all - tutte 396.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 396.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.257 0 0 0 0 0 939 959 1.702 405 1.070 658 524
2021/20227.902 212 961 816 688 225 438 427 430 891 607 1.239 968
2022/20237.691 1.000 615 410 558 962 1.174 370 689 963 183 469 298
2023/20246.193 242 364 373 611 1.307 501 594 655 145 384 413 604
2024/202516.486 663 224 296 1.315 3.092 2.336 829 931 1.887 1.376 1.659 1.878
2025/202620.021 1.673 1.206 2.549 4.695 7.278 2.620 0 0 0 0 0 0
Totale 96.822